Approval · Notice of Compliance 15771 · 2014
DICLECTIN: Notice of Compliance 15771
Issued July 4, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15771
- Date
- July 4, 2014
- Company
- Duchesnay Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- The inclusion of clinical and pharmacokinetic study information into the product monograph
- Therapeutic class
- Antinauseant against nausea and vomiting of pregnancy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DICLECTIN | Not yet assigned | — |
Medicinal ingredients
- DOXYLAMINE SUCCINATE 10 MG per TAB
- PYRIDOXINE HYDROCHLORIDE 10 MG per TAB